StockTipsArenaBeta

BUY Zydus Wellness Limited — Siddharth Rai Mangala

BUYZydus Wellness Limited
Zydus Wellness share price target & all analyst calls

bySiddharth Rai MangalaHorizon: NA (inferred 1–3 months)29 Jun 2026via Zee Business (Live)

Entry₹543.45Stated
Target₹650
Total upside +19.61% (call closed)
Stop loss₹490-9.84% risk
Exit₹49024 Aug 2026, 12:00 am
Stop-loss hit-9.84%
Follow Siddharth Rai Mangala for new calls(33% target hit, 15 closed calls)Get alertsWatch ZYDUSWELL for new buy/sell callsGet alertsSee 1 active Short-term call on ZYDUSWELLSee 39 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 24 Aug 2026
3 supporting3 neutral3 opposing
Supports the BUY call (3)

Zydus Wellness reported a consolidated growth of 66.7% in Net Sales for Q1 FY27, reaching ₹14,299 million. EBITDA grew by 55.3% to ₹2,417 million, and Net Profit stood at ₹1,189 million. Several brand

BSE · Company Update·4 Aug · 3w ago

(opens in new tab)

Zydus Wellness reported a consolidated growth of 66.7% in Net Sales for Q1 FY27, reaching ₹14,299 million. EBITDA grew by 55.3% to ₹2,417 million, and Net Profit stood at ₹1,189 million. The company s

NSE · Press Release·4 Aug · 3w ago

(opens in new tab)

1 advisor has an active long-term BUY call on this stock

Advisor consensus · adjacent horizon·4 Aug · 3w ago

Neutral / worth noting (3)

Care Ratings Limited has assigned a credit rating of CARE AA+; Stable for the long-term bank facilities of Zydus Wellness Products Limited, a wholly owned subsidiary.

BSE · Company Update·19 Aug · 4d ago

(opens in new tab)

Zydus Wellness Ltd announced the outcome of its Board Meeting held on August 4, 2026. The Board approved the unaudited financial results for the quarter ended June 30, 2026. The trading window will re

BSE · Board Meeting·4 Aug · 3w ago

(opens in new tab)

Zydus Wellness Limited announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved these results based on the Audit Committee's recommendations.

NSE · Outcome of Board Meeting·4 Aug · 3w ago

(opens in new tab)
Weighs against the BUY call (3)

Zydus Wellness slips 5% as Q1 profit falls 7%, margin pressure weighs

NewsCnbc-Tv18·4 Aug · 3w ago

(opens in new tab)

Zydus Wellness Share Price Falls Over 3% After Q1 Net Profit Declines

NewsNdtv-Profit·4 Aug · 3w ago

(opens in new tab)

Zydus Wellness Q1 Results: Profit Falls 7% Even As Revenue Jumps 67%, Margin Narrows

NewsNdtv-Profit·4 Aug · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Zydus Wellness

All analyst calls on Zydus Wellness

More from Siddharth Rai Mangala

Every call and its outcome